UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 556 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 556 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $1,000 | 0.0% | 556 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,000 | -50.0% | 556 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $2,000 | -33.3% | 556 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $3,000 | 0.0% | 556 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $3,000 | 0.0% | 556 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $3,000 | +50.0% | 556 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $2,000 | -60.0% | 556 | 0.0% | 0.00% | -75.0% |
Q2 2020 | $5,000 | +66.7% | 556 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $3,000 | -25.0% | 556 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $4,000 | +33.3% | 556 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $3,000 | -40.0% | 556 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $5,000 | 0.0% | 556 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $5,000 | -44.4% | 556 | 0.0% | 0.00% | -42.9% |
Q4 2018 | $9,000 | 0.0% | 556 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $9,000 | – | 556 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
Leap Investments LP | 13,400 | $78,000 | 0.11% |
Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |